Lloyd-Smith Malcolm 4
4 · NEUROCRINE BIOSCIENCES INC · Filed Feb 2, 2022
Insider Transaction Report
Form 4
Lloyd-Smith Malcolm
Chief Regulatory Officer
Transactions
- Award
Restricted Stock Unit
2022-01-31+3,164→ 3,164 total→ Common Stock (3,164 underlying) - Award
Stock Option
2022-01-31+21,546→ 21,546 totalExercise: $79.02Exp: 2032-01-31→ Common Stock (21,546 underlying)
Footnotes (3)
- [F1]Represents option of which 1/12th of the shares underlying the option becomes vested and exercisable on February 28, 2022 and an additional 1/12th of the shares underlying the option becomes vested and exercisable each month thereafter.
- [F2]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock.
- [F3]The Restricted Stock Units vests in full on the first anniversary of the date of grant.